Adams–Oliver syndrome
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor-in-Chief: Edzel Lorraine Co, DMD, MD[2]
Overview
Adams-Oliver syndrome (AOS) is an autosomal dominant disorder which involves the mutation of six genes, namely the ARHGAP31, DLL4, DOCK6, EOGT, NOTCH1, and RBPJ genes. [1] This disorder has an incidence of 44 per 10 million. Patients who have this condition typically present with some cardiovascular defects, terminal transverse limb defects (TTLD), neurologic findings, growth deficiency, accessory nipples, cryptorchidism, renal abnormalities, aplasia cutis congenita (ACC), and Poland sequence. [2]
Historical Perspective
- Adams-Oliver syndrome was first described by American pediatric cardiologist Forrest H. Adams and Charles P. Oliver, a clinical geneticist, in 1945 after they had identified presence of terminal transverse defects of the limbs and aplasia cutis congenita of scalp in eight members of a three-generation family [3].
- This condition is associated with genetic mutations in DLL4, ARHGAP31, NOTCH1 and RBPJ leading to an autosomal dominant with variable penetrance expression, and EOGT and DOCK6 mutations causing autosomal recessive expression [4] [5] [6] [7] [8] [9].
- Congenital vasculopathy is believed to be the underlying mechanism in the pathogenesisof AOS [10].
Classification
- Adams-Oliver syndrome may be classified according to American College of Medical Genetics (ACMG) guidelines into five subtypes/ groups:
- AOS can also be classified into six types according to location of mutation and mode of inheritance. These are:
Pathophysiology
- The pathogenesis of Adams-Oliver syndrome still remains unidentified.
- However, several mechanisms of this disease have been proposed, which includes:
- Compromise of the vasculature such as congenital, developmental defects, pericyte recruitment to vessel abnormalities, or blood supply interruption in the early embryonic stages [13]
- Genetic factors
- Trauma
- Teratogens (carbimazole, misoprostol, valproic acid, and methimazole [14].
Causes
- AOS is believed to be caused by genetic mutations with symptoms vary depending on the involved gene.
Differentiating Adams-Oliver syndrome from other Diseases
- Adams-Oliver syndrome must be differentiated from other diseases that cause syndromic aplasia cutis congenita, and terminal transverse limb defect, such as:
Epidemiology and Demographics
Age
Gender
Race
Risk Factors
- Risk factors associated in the development of AOS include having a family history of AOS and being born to parents with consanguineous marriage [17].
Natural History, Complications and Prognosis
- The majority of patients with Adams-Oliver Syndrome remain asymptomatic for [duration/years].
- Early clinical features include [manifestation 1], [manifestation 2], and [manifestation 3].
- If left untreated, [#%] of patients with Adams-Oliver Syndrome may progress to develop [manifestation 1], [manifestation 2], and [manifestation 3].
- Common complications of [disease name] include [complication 1], [complication 2], and [complication 3].
- Prognosis is generally [excellent/good/poor], and the [1/5/10year mortality/survival rate] of patients with [disease name] is approximately [#%].
Diagnosis
Diagnostic Criteria
- The diagnosis of Adams-Oliver Syndrome is made when at least one of the following diagnostic criteria are met in a proband:
- Present of TTLD and ACC of the scalp
- TTLD or ACC and a first-degree relative manifesting with similar conditions suggestive of AOS
- TTLD or ACC and the presence of either one pathogenic variant in the autosomal dominant AOS-associated gene (DLL4, ARHGAP31, RBPJ, or NOTCH1), or two pathogenic variants in the autosomal recessive AOS-associated gene (EOGT or DOCK6) [18]
History and Symptoms
- Adams-Oliver Syndrome is usually asymptomatic.
Physical Examination
- Patients with AOS may be remarkable for:
- Congenital scalp defects, increased head circumference
- Hyperpigmentation of the skin, telangiectatic lesions
- Facial asymmetry
- Congenital structural eye defects
- Cleft lip/ palate, deep philtrum, teeth crowding, deviated jaw, retrognathia
- Hypoplasia of the distal extremities, polydactyly, syndactyly, congenital hip dislocation
- Cardiac and vascular abnormalities
- Supernumerary nipples
- Hydronephrosis,cryptorchidism
- Intellectual disability
- Neurologic abnormalities [19]
Laboratory Findings
- There are no specific laboratory findings associated with AOS.
Electrocardiogram
There are no ECG findings associated with [disease name].
OR
An ECG may be helpful in the diagnosis of [disease name]. Findings on an ECG suggestive of/diagnostic of [disease name] include [finding 1], [finding 2], and [finding 3].
X-ray
There are no x-ray findings associated with [disease name].
OR
An x-ray may be helpful in the diagnosis of [disease name]. Findings on an x-ray suggestive of/diagnostic of Adams-Oliver Syndrome include [finding 1], [finding 2], and [finding 3].
OR
There are no x-ray findings associated with Adams-Oliver Syndrome. However, an x-ray may be helpful in the diagnosis of complications of [disease name], which include [complication 1], [complication 2], and [complication 3].
Echocardiography
Echocardiography/ultrasound may be helpful in the diagnosis of Adams-Oliver Syndrome. Findings on an echocardiography/ultrasound suggestive of/diagnostic of Adams-Oliver Syndrome include [[[ventricular septal defect]] (VSD), patent ductus arterioles, and systolic pulmonary artery pressure [20].
CT scan
There are no CT scan findings associated with AOS.
Magenetic Resonance Imaging (MRI)
MRI of the brain may be helpful in the diagnosis of Adams-Oliver Syndrome. Findings on MRI suggestive of/diagnostic of Adams-Oliver Syndrome include increased head circumference, and alterations in the cerebral ventricles and meninges [20].
Other Imaging Findings
There are no other imaging findings associated with AOS.
Other Diagnostic Studies
There are no other diagnostic studies associated with AOS.
Treatment
Medical Therapy
- There is no treatment for Adams-Oliver Syndrome; the mainstay of therapy is supportive care.
- The mainstay of therapy for Adams-Oliver Syndrome is [medical therapy 1] and [medical therapy 2].
- [Medical therapy 1] acts by [mechanism of action 1].
- Response to [medical therapy 1] can be monitored with [test/physical finding/imaging] every [frequency/duration].
Surgery
- Surgery is the mainstay of therapy for Adams-Oliver Syndrome.
- [Surgical procedure] in conjunction with [chemotherapy/radiation] is the most common approach to the treatment of [disease name].
- [Surgical procedure] can only be performed for patients with [disease stage] [disease name].
Prevention
- There are no primary preventive measures available for [disease name].
- Effective measures for the primary prevention of [disease name] include [measure1], [measure2], and [measure3].
- Once diagnosed and successfully treated, patients with [disease name] are followed-up every [duration]. Follow-up testing includes [test 1], [test 2], and [test 3].
References
- ↑ Hassed S, Li S, Mulvihill J, Aston C, Palmer S (2017). "Adams-Oliver syndrome review of the literature: Refining the diagnostic phenotype". Am J Med Genet A. 173 (3): 790–800. doi:10.1002/ajmg.a.37889. PMID 28160419.
- ↑ 2.0 2.1 Lacoste J, Bertrand A, Karcher G, Martin J (1978). "[Dynamic and topographic measurement of lung gas exchange by means of intravenous Xenon 133 and illustrated with the aid of a computer]". Lille Med. 23 (6): 406–11. PMID https://www.ncbi.nlm.nih.gov/books/NBK355754/ Check
|pmid=
value (help). - ↑ Rashid S, Azeem S, Riaz S (2022). "Adams-Oliver Syndrome: A Rare Congenital Disorder". Cureus. 14 (3): e23297. doi:10.7759/cureus.23297. PMC 9012592 Check
|pmc=
value (help). PMID 35449659 Check|pmid=
value (help). - ↑ Shaheen R, Aglan M, Keppler-Noreuil K, Faqeih E, Ansari S, Horton K; et al. (2013). "Mutations in EOGT confirm the genetic heterogeneity of autosomal-recessive Adams-Oliver syndrome". Am J Hum Genet. 92 (4): 598–604. doi:10.1016/j.ajhg.2013.02.012. PMC 3617382. PMID 23522784.
- ↑ Hassed SJ, Wiley GB, Wang S, Lee JY, Li S, Xu W; et al. (2012). "RBPJ mutations identified in two families affected by Adams-Oliver syndrome". Am J Hum Genet. 91 (2): 391–5. doi:10.1016/j.ajhg.2012.07.005. PMC 3415535. PMID 22883147.
- ↑ Shaheen R, Faqeih E, Sunker A, Morsy H, Al-Sheddi T, Shamseldin HE; et al. (2011). "Recessive mutations in DOCK6, encoding the guanidine nucleotide exchange factor DOCK6, lead to abnormal actin cytoskeleton organization and Adams-Oliver syndrome". Am J Hum Genet. 89 (2): 328–33. doi:10.1016/j.ajhg.2011.07.009. PMC 3155174. PMID 21820096.
- ↑ Southgate L, Machado RD, Snape KM, Primeau M, Dafou D, Ruddy DM; et al. (2011). "Gain-of-function mutations of ARHGAP31, a Cdc42/Rac1 GTPase regulator, cause syndromic cutis aplasia and limb anomalies". Am J Hum Genet. 88 (5): 574–85. doi:10.1016/j.ajhg.2011.04.013. PMC 3146732. PMID 21565291.
- ↑ Stittrich AB, Lehman A, Bodian DL, Ashworth J, Zong Z, Li H; et al. (2014). "Mutations in NOTCH1 cause Adams-Oliver syndrome". Am J Hum Genet. 95 (3): 275–84. doi:10.1016/j.ajhg.2014.07.011. PMC 4157158. PMID 25132448.
- ↑ Meester JA, Southgate L, Stittrich AB, Venselaar H, Beekmans SJ, den Hollander N; et al. (2015). "Heterozygous Loss-of-Function Mutations in DLL4 Cause Adams-Oliver Syndrome". Am J Hum Genet. 97 (3): 475–82. doi:10.1016/j.ajhg.2015.07.015. PMC 4564989. PMID 26299364.
- ↑ Swartz EN, Sanatani S, Sandor GG, Schreiber RA (1999). "Vascular abnormalities in Adams-Oliver syndrome: cause or effect?". Am J Med Genet. 82 (1): 49–52. doi:10.1002/(sici)1096-8628(19990101)82:1<49::aid-ajmg10>3.0.co;2-m. PMID 9916843.
- ↑ Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J; et al. (2015). "Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology". Genet Med. 17 (5): 405–24. doi:10.1038/gim.2015.30. PMC 4544753. PMID 25741868.
- ↑ https://accesspediatrics.mhmedical.com/content.aspx?bookid=2674§ionid=220520418 Adams-Oliver Syndrome (AOS) | Syndromes: Rapid Recognition and Perioperative Implications, 2e | AccessPediatrics | McGraw Hill Medical
- ↑ https://accesspediatrics.mhmedical.com/content.aspx?bookid=2674§ionid=220520418 Adams-Oliver Syndrome (AOS) | Syndromes: Rapid Recognition and Perioperative Implications, 2e | AccessPediatrics | McGraw Hill Medical
- ↑ 14.0 14.1 14.2 Zakanj Z, Bedek D, Kotrulja L, Ozanic Bulic S (2016). "Adams-Oliver syndrome in a newborn infant". Int J Dermatol. 55 (2): 215–7. doi:10.1111/ijd.12469. PMID 24697559.
- ↑ Saeidi M, Ehsanipoor F (2017). "A Case of Adams-Oliver Syndrome". Adv Biomed Res. 6: 167. doi:10.4103/2277-9175.221861. PMC 5767801. PMID 29387678.
- ↑ MedlinePlus [Internet]. Bethesda (MD): National Library of Medicine (US); [updated 2015 Nov 1]. Adams-Oliver syndrome; [updated 2015 Nov 1; [about 5 p.]. Available from: https://medlineplus.gov/genetics/condition/adams-oliver-syndrome/
- ↑ Bakry O, Attia A, El Shafey EN (2012). "Adams-Oliver Syndrome. A case with isolated aplasia cutis congenita and skeletal defects". J Dermatol Case Rep. 6 (1): 25–8. doi:10.3315/jdcr.2012.1092. PMC 3322107. PMID 22514587.
- ↑ Lehman A, Wuyts W, Patel MS. Adams-Oliver Syndrome. 2016 Apr 14. In: Adam MP, Mirzaa GM, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2023.https://www.ncbi.nlm.nih.gov/books/NBK355754/ Adams-Oliver Syndrome - GeneReviews® - NCBI Bookshelf |
- ↑ Verdyck P, Holder-Espinasse M, Hul WV, Wuyts W (2003). "Clinical and molecular analysis of nine families with Adams-Oliver syndrome". Eur J Hum Genet. 11 (6): 457–63. doi:10.1038/sj.ejhg.5200980. PMID 12774039.
- ↑ 20.0 20.1 Frantz JA, Lehmkuhl RL, Leitis LH, Uliano VG, Siementcoski GA (2015). "Adams-Oliver syndrome: a case report". Pediatr Dermatol. 32 (3): 383–5. doi:10.1111/pde.12423. PMID 25556654.